XML 97 R66.htm IDEA: XBRL DOCUMENT
v3.22.4

Information by segment and main country - Reconciliation from net income to Adjusted EBITA (Detail) - EUR (€) € in Millions | 12 Months Ended
--- | ---
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Profit (loss) |  | € (1,605) | [1] | € 3,323 | [2] | € 1,195 | [2]
Profit (loss) from discontinued operations |  | 13 | [2] | 2,711 | [2] | 196 | [1]
Tax expense (income) |  | (113) |  | (103) |  | 212 |
Share of profit (loss) of associates and joint ventures accounted for using equity method |  | (2) |  | (4) |  | (9) |
Finance costs |  | 258 |  | 188 |  | 202 |
Finance income |  | 58 |  | 149 |  | 158 |
Profit (loss) from operating activities |  | (1,529) |  | 553 |  | 1,264 |
Amortization of acquired intangible assets | [2] | 363 |  | 322 |  | 377 |
Impairment loss recognised in profit or loss, goodwill | [2] | 1,357 |  | 15 |  | 144 |
Earnings before interest, taxes and amortization |  | 192 |  | 890 |  | 1,784 |
Restructuring and acquisition-related charges | [2] | 202 |  | 95 |  | 195 |
Other items | [2] | 925 |  | 1,069 |  | 299 |
Adjusted EBITA |  | 1,318 |  | 2,054 |  | 2,277 |
Respironics field-action provision [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 250 |  | 719 |  |  |
Respironics field-action running remediation costs [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 210 |  | 94 |  |  |
R&D project impairments [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 134 |  |  |  |  |
Portfolio realignment charges [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 109 |  |  |  |  |
Impairment of assets in S&RC [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 39 |  |  |  |  |
Provision for public investigations tender irregularities [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 60 |  |  |  |  |
Provisions for quality actions in Connected Care [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 59 |  | 94 |  |  |
Remaining items [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 63 |  | 87 |  | 299 |
Loss on divestment of business [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] |  |  | 76 |  |  |
Diagnosis & Treatment [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Profit (loss) from operating activities |  | 404 |  | 941 |  | 497 |
Amortization of acquired intangible assets |  | 143 |  | 153 |  | 209 |
Impairment loss recognised in profit or loss, goodwill |  | 27 |  | 2 |  | 0 |
Earnings before interest, taxes and amortization |  | 573 |  | 1,097 |  | 706 |
Restructuring and acquisition-related charges |  | 21 |  | 7 |  | 29 |
Other items |  | 180 |  | (32) |  | 83 |
Adjusted EBITA |  | 774 |  | 1,071 |  | 818 |
Diagnosis & Treatment [Member] | Respironics field-action provision [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  |  |  | 0 |  |  |
Diagnosis & Treatment [Member] | R&D project impairments [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 120 |  |  |  |  |
Diagnosis & Treatment [Member] | Provision for public investigations tender irregularities [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 60 |  |  |  |  |
Diagnosis & Treatment [Member] | Remaining items [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 0 |  | (32) |  |  |
Connected Care [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Profit (loss) from operating activities |  | (2,246) |  | (722) |  | 704 |
Amortization of acquired intangible assets |  | 199 |  | 148 |  | 134 |
Impairment loss recognised in profit or loss, goodwill |  | 1,331 |  | 13 |  | 144 |
Earnings before interest, taxes and amortization |  | (716) |  | (562) |  | 982 |
Restructuring and acquisition-related charges |  | 108 |  | 93 |  | 97 |
Other items |  | 703 |  | 965 |  | 112 |
Adjusted EBITA |  | 95 |  | 497 |  | 1,191 |
Connected Care [Member] | Respironics field-action provision [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 250 |  | 719 |  |  |
Connected Care [Member] | Respironics field-action running remediation costs [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 210 |  | 94 |  |  |
Connected Care [Member] | R&D project impairments [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 12 |  |  |  |  |
Connected Care [Member] | Portfolio realignment charges [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 109 |  |  |  |  |
Connected Care [Member] | Impairment of assets in S&RC [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 39 |  |  |  |  |
Connected Care [Member] | Provisions for quality actions in Connected Care [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 59 |  | 94 |  |  |
Connected Care [Member] | Remaining items [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 24 |  | 58 |  |  |
Personal Health [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Profit (loss) from operating activities |  | 515 |  | 576 |  | 362 |
Amortization of acquired intangible assets |  | 15 |  | 15 |  | 16 |
Earnings before interest, taxes and amortization |  | 531 |  | 591 |  | 378 |
Restructuring and acquisition-related charges |  | 11 |  | (1) |  | 31 |
Other items |  | (4) |  | 0 |  | 24 |
Adjusted EBITA |  | 538 |  | 590 |  | 433 |
Personal Health [Member] | R&D project impairments [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 3 |  |  |  |  |
Personal Health [Member] | Remaining items [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | (6) |  | 0 |  |  |
Other [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Profit (loss) from operating activities |  | (202) |  | (242) |  | (300) |
Amortization of acquired intangible assets |  | 7 |  | 6 |  | 18 |
Earnings before interest, taxes and amortization |  | (196) |  | (236) |  | (282) |
Restructuring and acquisition-related charges |  | 61 |  | (5) |  | 37 |
Other items |  | 46 |  | 136 |  | 81 |
Adjusted EBITA |  | (89) |  | (105) |  | € (165) |
Other [Member] | Respironics field-action provision [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  |  |  | 0 |  |  |
Other [Member] | Remaining items [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | € 46 |  | 61 |  |  |
Other [Member] | Loss on divestment of business [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  |  |  | € 76 |  |  |
[1] | Shareholders in this table refers to shareholders of Koninklijke Philips N.V.
[2] | Shareholders in this table refers to shareholders of Koninklijke Philips N.V.

X
- Definition The amount of costs associated with financing activities of the entity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 82 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_b&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_FinanceCosts
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of income associated with interest and other financing activities of the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 85 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_FinanceIncome
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2021-01-01 -Paragraph B67 -Subparagraph d -Clause v -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d_v&doctype=Appendix&subtype=B -URIDate 2021-03-24 + Details
Name: | ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 26 -IssueDate 2021-01-01 -Paragraph 35 -Subparagraph b -Clause viii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 23 -Subparagraph h -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard -URIDate 2021-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2021-01-01 -Paragraph 79 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard -URIDate 2021-03-24 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2021-01-01 -Paragraph 81 -Subparagraph c -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard -URIDate 2021-03-24 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 82 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard -URIDate 2021-03-24 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2021-01-01 -Paragraph 81 -Subparagraph c -Clause ii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard -URIDate 2021-03-24 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2021-01-01 -Paragraph B13 -Subparagraph g -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B -URIDate 2021-03-24 + Details
Name: | ifrs-full_IncomeTaxExpenseContinuingOperations
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2021-01-01 -Paragraph 18 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2021-01-01 -Paragraph 24 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard -URIDate 2021-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2021-01-01 -Paragraph 32 -Subparagraph a -Clause ii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard -URIDate 2021-03-24 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 28 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard -URIDate 2021-03-24 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Note Effective on first application of IFRS 9 -Name IFRS -Number 4 -IssueDate 2021-01-01 -Paragraph 39L -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard -URIDate 2021-03-24 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 23 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard -URIDate 2021-03-24 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Note Effective 2023-01-01 -Name IFRS -Number 17 -IssueDate 2021-01-01 -Paragraph 113 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard -URIDate 2021-03-24 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2021-01-01 -Paragraph B10 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2021-03-24 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 106 -Subparagraph d -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard -URIDate 2021-03-24 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 81A -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_ProfitLoss
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2021-01-01 -Paragraph 33 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2021-01-01 -Paragraph B12 -Subparagraph b -Clause vii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_vii&doctype=Appendix&subtype=B -URIDate 2021-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 82 -Subparagraph ea -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_ea&doctype=Standard -URIDate 2021-03-24 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 98 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_e&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_ProfitLossFromDiscontinuedOperations
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The profit (loss) from operating activities of the entity. [Refer: Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 32 -IssueDate 2021-01-01 -Paragraph IE33 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_IE33&doctype=Illustrative%20Examples -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 85 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_ProfitLossFromOperatingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 23 -Subparagraph g -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_g&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 28 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard -URIDate 2021-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective on first application of IFRS 9 -Name IFRS -Number 4 -IssueDate 2021-01-01 -Paragraph 39M -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39M_b&doctype=Standard -URIDate 2021-03-24 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 82 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_c&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_AdjustedEbita
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_AmortizationOfAcquiredIntangibleAssets
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EarningsBeforeInterestTaxesAndAmortization
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_InformationBySegmentAndMainCountryLineItems
Namespace Prefix: | phg_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_OtherItems
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_RestructuringAndAcquisitionRelatedCharges
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_RespironicsFieldActionProvisionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_RespironicsFieldActionRunningRemediationCostsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_RDProjectImpairmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_PortfolioRealignmentChargesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_ImpairmentOfAssetsInSRcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_ProvisionForPublicInvestigationsTenderIrregularitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_ProvisionsForQualityActionsInConnectedCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_RemainingItemsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_LossOnDivestmentOfBusinessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_DiagnosisTreatmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_ConnectedCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_PersonalHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_OtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |